|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
PaxVax, Redwood City
| | | Phone: | (650) 847-1075 | Year Established: | 2007 | Employees: | 180 | Main Contact: | Piers Whitehead, Executive VP & CBO | | Other Contacts: | Mark Meltz, Executive VP & CLO Paul Shabram, VP, Technical Development Jonathan F. Smith, Executive VP & CSO Marc Gurwith, CMO Nima Farzan, President & CEO Tom Yonker, VP, Project Management Paul Shabram, VP, Technical Development Philip Moody, Executive VP & CFO Kurt Reichen, VP, Technical Operations
| | Company Description | PaxVax is a fully integrated specialty vaccine company with a mission to protect people from infectious diseases. The company seeks both financial returns through two specialty business strategies in travel and biodefense vaccines as well as social returns by providing access to its vaccines globally and by developing vaccines addressing some of the world’s most lethal infectious diseases. The PaxVax portfolio includes a licensed vaccine for typhoid (Vivotif®), vaccines in clinical development for cholera, anthrax, HIV, and H5N1 (pandemic bird flu) and in research for malaria, dengue, rabies and HSV. PaxVax is headquartered in Redwood City, California and maintains research and development and Good Manufacturing Practice (GMP) facilities in San Diego, California, USA, and its newly acquired facility near Bern, Switzerland. | |
|
|
|
|
|